Zhou et al. [46] demonstrated that miR-223 down-regulates the NLRP3 inflammasome and the Keap1/Nrf2 signaling pathway, thereby reducing inflammation and oxidative damage associated with the mastitis process. The gene discussed is NLRP3; the disease is mastitis.